SEOM clinical guidelines for hereditary cancer

被引：14
作者：
Grana, Begona [1 ,2 ]
Lastra, Enrique [3 ]
Llort, Gemma [4 ]
Brunet, Joan [5 ]
Isla, Dolores [6 ]
机构：
[1] VHIO, Dept Med Oncol, High Risk & Canc Prevent Unit, ES-08035 Barcelona, Spain
[2] Marcide Hosp, Ferrol Healthcare Area, La Coruna, Spain
[3] Gen Yague Hosp, Med Oncol Sect, Genet Counselling Unit, Burgos, Spain
[4] Valles Inst Oncol, Genet Counselling Unit, Barcelona, Spain
[5] ICO, Hereditary Canc Program, Dept Med Oncol, Girona, Spain
[6] Lozano Blesa Hosp, Dept Med Oncol, Zaragoza, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 08期
关键词：
Hereditary cancer; BRCA1; BRCA2; Lynch syndrome; BRCA2 MUTATION CARRIERS; NONPOLYPOSIS COLORECTAL-CANCER; OVARIAN-CANCER; LYNCH-SYNDROME; BREAST-CANCER; SALPINGO-OOPHORECTOMY; INHERITED MUTATIONS; YOUNG-WOMEN; RISK; FAMILIES;
D O I：
10.1007/s12094-011-0701-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Research in genetics has facilitated the identification of highly penetrant genes responsible for a large number of diseases. In the oncology field, genetic counselling and gene testing are focused on the two most common syndromes in familial cancer: hereditary breast and ovarian cancer syndrome (HBOC) and hereditary non-polyposis colorectal cancer or Lynch syndrome (LS). The objective of this guideline in hereditary cancer is to summarise the current state of knowledge and make recommendations in the areas of diagnosis, prevention and treatment of hereditary cancer.
引用
收藏
页码：580 / 586
页数：7
相关论文
共 24 条
  • [1] Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study
    Antoniou, Antonis C.
    Rookus, Matti
    Andrieu, Nadine
    Brohet, Richard
    Chang-Claude, Jenny
    Peock, Susan
    Cook, Margaret
    Evans, D. Gareth
    Eeles, Rosalind
    Nogues, Catherine
    Faivre, Laurence
    Gesta, Paul
    van Leeuwen, Flora E.
    Ausems, Margreet G. E. M.
    Sorio, Ana
    Caldes, Trinidad
    Simard, Jacques
    Lubinski, Jan
    Gerdes, Anne-Marie
    Olah, Edith
    Fuerhauser, Christine
    Olsson, Hakan
    Arver, Brita
    Radice, Paolo
    Easton, Douglas F.
    Goldgarl, David E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 601 - 610
  • [2] Prediction of MLH1 and MSH2 mutations in Lynch syndrome
    Balmana, Judith
    Stockwell, David H.
    Steyerberg, Ewout W.
    Stoffel, Elena M.
    Deffenbaugh, Amie M.
    Reid, Julia E.
    Ward, Brian
    Scholl, Thomas
    Hendrickson, Brant
    Tazelaar, John
    Burbidge, Lynn Anne
    Syngal, Sapna
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12): : 1469 - 1478
  • [3] Meta-analysis of BRCA1 and BRCA2 penetrance
    Chen, Sining
    Parmigiani, Giovanni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1329 - 1333
  • [4] Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
    Domchek, SM
    Friebel, TM
    Neuhausen, SL
    Wagner, T
    Evans, G
    Isaacs, C
    Garber, JE
    Daly, M
    Eeles, R
    Matloff, E
    Tomlinson, GE
    Van't Veer, L
    Lynch, HT
    Olopade, O
    Weber, BL
    Rebbeck, TR
    [J]. LANCET ONCOLOGY, 2006, 7 (03) : 223 - 229
  • [5] Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
    Domchek, Susan M.
    Friebel, Tara M.
    Singer, Christian F.
    Evans, D. Gareth
    Lynch, Henry T.
    Isaacs, Claudine
    Garber, Judy E.
    Neuhausen, Susan L.
    Matloff, Ellen
    Eeles, Rosalind
    Pichert, Gabriella
    Van T'veer, Laura
    Tung, Nadine
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Rubinstein, Wendy S.
    Ganz, Patricia A.
    Daly, Mary B.
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Schildkraut, Joellen
    Blum, Joanne L.
    Rebbeck, Timothy R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09): : 967 - 975
  • [6] Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
    Hampel, Heather
    Frankel, Wendy L.
    Martin, Edward
    Arnold, Mark
    Khanduja, Karamjit
    Kuebler, Philip
    Clendenning, Mark
    Sotamaa, Kaisa
    Prior, Thomas
    Westman, Judith A.
    Panescu, Jenny
    Fix, Dan
    Lockman, Janet
    LaJeunesse, Jennifer
    Comeras, Ilene
    de la Chapelle, Albert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5783 - 5788
  • [7] Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
    Järvinen, HJ
    Aarnio, M
    Mustonen, H
    Aktan-Collan, K
    Aaltonen, LA
    Peltomäki, P
    de la Chapelle, A
    Mecklin, JP
    [J]. GASTROENTEROLOGY, 2000, 118 (05) : 829 - 834
  • [8] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1382 - 1384
  • [9] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    King, MC
    Wieand, S
    Hale, K
    Lee, M
    Walsh, T
    Owens, K
    Tait, J
    Ford, L
    Dunn, BK
    Costantino, J
    Wickerham, L
    Wolmark, N
    Fisher, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2251 - 2256
  • [10] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    [J]. SCIENCE, 2003, 302 (5645) : 643 - 646
123